Elizandra Braganhol Selected Research

Elizandra Braganhol Research Topics

Disease

42	Neoplasms (Cancer) 12/2023 - 07/2006
37	Glioma (Gliomas) 01/2023 - 08/2003
20	Glioblastoma (Glioblastoma Multiforme) 04/2023 - 08/2009
14	Inflammation (Inflammations) 12/2021 - 08/2009
9	Necrosis 08/2021 - 02/2009
5	Brain Neoplasms (Brain Tumor) 04/2023 - 08/2007
4	Mitochondrial Diseases (Mitochondrial Disease) 04/2018 - 02/2011
3	Melanoma (Melanoma, Malignant) 08/2023 - 04/2018
3	Hemolysis 11/2020 - 06/2015
3	Hypermethioninemia 04/2020 - 10/2017
2	Neoplasm Metastasis (Metastasis) 08/2023 - 06/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2020 - 03/2010
2	Papillary Thyroid Cancer 01/2019 - 06/2018
2	Mania (Manias) 10/2016 - 02/2014
2	Down Syndrome (Down's Syndrome) 08/2015 - 06/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2014 - 05/2010
2	Carcinogenesis 09/2014 - 07/2006
2	Thrombosis (Thrombus) 12/2013 - 03/2010
2	Hyperhomocysteinemia 12/2013 - 03/2010
2	Familial Polythelia 10/2009 - 02/2009
1	Medulloblastoma 12/2023
1	Central Nervous System Neoplasms 08/2023
1	Alcoholic Fatty Liver 06/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023
1	Sepsis (Septicemia) 12/2021
1	Hepatocellular Carcinoma (Hepatoma) 12/2021
1	Pneumonia (Pneumonitis) 12/2021
1	Neuroinflammatory Diseases 12/2020
1	Wounds and Injuries (Trauma) 12/2020
1	Memory Disorders (Memory Loss) 12/2020
1	Vascular Diseases (Vascular Disease) 09/2020

Drug/Important Bio-Agent (IBA)

18	Adenosine Triphosphate (ATP)IBA 01/2021 - 08/2003
14	Adenosine (Adenocard)FDA LinkGeneric 04/2023 - 04/2006
12	EnzymesIBA 04/2023 - 08/2003
11	NanocapsulesIBA 11/2020 - 08/2009
9	Adenosine Monophosphate (AMP)IBA 04/2023 - 08/2003
9	5'-Nucleotidase (5' Nucleotidase)IBA 01/2019 - 08/2003
8	Temozolomide (Temodar)FDA LinkGeneric 08/2023 - 02/2009
8	Proteins (Proteins, Gene)FDA Link 04/2023 - 12/2008
8	NucleotidesIBA 12/2022 - 08/2003
8	AntioxidantsIBA 12/2020 - 10/2009
8	Adenosine Diphosphate (ADP)IBA 01/2020 - 08/2003
5	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 07/2023 - 05/2019
4	Rosmarinic AcidIBA 12/2023 - 01/2019
4	Purinergic Receptors (Receptors, Purine)IBA 10/2022 - 01/2013
4	ectoATPaseIBA 12/2021 - 08/2009
4	LipidsIBA 12/2020 - 02/2013
4	Apyrase (ATP Diphosphatase)IBA 01/2020 - 08/2009
4	Propidium (Propidium Iodide)IBA 01/2020 - 02/2009
4	adenylyl(3'-5')cytidine-3'-phosphateIBA 05/2019 - 09/2007
4	Messenger RNA (mRNA)IBA 01/2019 - 12/2008
4	CurcuminIBA 03/2015 - 06/2012
3	ChitosanIBA 08/2023 - 01/2020
3	Conditioned Culture MediaIBA 01/2022 - 05/2015
3	LipopolysaccharidesIBA 12/2021 - 01/2015
3	NitritesIBA 04/2020 - 09/2019
3	adenosine monophosphataseIBA 04/2020 - 01/2017
3	CatalaseIBA 01/2018 - 12/2016
3	Adenine NucleotidesIBA 08/2015 - 04/2006
2	PhytochemicalsIBA 12/2023 - 03/2015
2	CD39 antigenIBA 12/2021 - 06/2018
2	Neuroprotective AgentsIBA 12/2020 - 07/2018
2	ArginaseIBA 06/2020 - 04/2020
2	Methionine (L-Methionine)FDA Link 04/2020 - 01/2020
2	Small Interfering RNA (siRNA)IBA 04/2020 - 11/2019
2	methionine sulfoxideIBA 04/2020 - 01/2020
2	diphenyldiselenideIBA 01/2020 - 09/2019
2	Oxygen (Dioxygen)IBA 04/2018 - 01/2018
2	Superoxide DismutaseIBA 01/2018 - 01/2017
2	Complex MixturesIBA 01/2018 - 02/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 10/2016
2	Ketamine FDA LinkGeneric 10/2016 - 02/2014
2	Biomarkers (Surrogate Marker)IBA 08/2015 - 09/2014
2	Ketoprofen (Orudis)FDA LinkGeneric 06/2015 - 12/2013
2	CytokinesIBA 05/2015 - 01/2015
2	Dihydrotachysterol (AT 10)IBA 10/2009 - 02/2009
2	QuercetinIBA 09/2007 - 07/2006
2	NucleotidasesIBA 09/2007 - 08/2003
1	LigandsIBA 12/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023
1	Alkylating AgentsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Gallic AcidIBA 12/2022
1	NucleosidesIBA 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	BromidesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 12/2021
1	Irritants (Vesicants)IBA 08/2021
1	AntigensIBA 01/2021
1	Thiobarbituric Acid Reactive SubstancesIBA 12/2020
1	Biopolymers (Biopolymer)IBA 12/2020
1	SuspensionsIBA 11/2020
1	Phosphates (Orthophosphate)IBA 09/2020

Therapy/Procedure

13	Therapeutics 04/2023 - 02/2011
6	Drug Therapy (Chemotherapy) 08/2023 - 08/2007
2	Intranasal Administration 01/2023 - 12/2020
2	Immunotherapy 01/2021 - 11/2019
2	Intravenous Administration 11/2020 - 06/2015
1	Ligation 12/2021